Remembering Johnson & Johnson or Why Are We Boosting?
edv1694.substack.com
A discussion on Twitter concerning Novavax and boosting got me wondering about the durability of the protection of other C-19 vaccines besides the mRNAs, whose efficacy is now known to wane rapidly. It is precisely due to this rapid waning in efficacy that public health authorities on both sides of the Atlantic recommend (and sometimes require) boosting. But what about Novavax? It has only been in use for a short time, so how can we know the durability of the protection it confers? Presumably there are not yet any studies on the issue.
Remembering Johnson & Johnson or Why Are We Boosting?
Remembering Johnson & Johnson or Why Are We…
Remembering Johnson & Johnson or Why Are We Boosting?
A discussion on Twitter concerning Novavax and boosting got me wondering about the durability of the protection of other C-19 vaccines besides the mRNAs, whose efficacy is now known to wane rapidly. It is precisely due to this rapid waning in efficacy that public health authorities on both sides of the Atlantic recommend (and sometimes require) boosting. But what about Novavax? It has only been in use for a short time, so how can we know the durability of the protection it confers? Presumably there are not yet any studies on the issue.